News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
216 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (5)
2 (305)
3 (298)
4 (217)
5 (233)
6 (147)
7 (5)
8 (2)
9 (236)
10 (272)
11 (253)
12 (267)
13 (130)
14 (5)
15 (14)
16 (219)
17 (216)
18 (216)
19 (181)
20 (159)
21 (10)
22 (15)
23 (179)
24 (237)
25 (208)
26 (209)
27 (139)
28 (19)
29 (10)
30 (258)
31 (244)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Pharm Country
Regeneron Could Begin COVID-19 Clinical Trials in Summer for Newly Identified Antibodies
Regeneron said it has identified hundreds of virus-neutralizing antibodies and intends to begin large-scale manufacturing by mid-April.
March 17, 2020
·
3 min read
·
Alex Keown
Biotech Bay
High Content Screening Market Trends and Growth Factors Analysis to 2025
High-content screening refers to a technique used in biological research and drug discovery to discover substances such as peptides, small molecules, or RNAi that change the phenotype of a cell as desired.
March 17, 2020
·
3 min read
Pharm Country
Global Antiseptic and Disinfectant Market to Expand with Improved Safety Standards across Healthcare
Antiseptic products of various types have glutted global markets. The growing consciousness of the masses towards healthier and disease-free lifestyles has given a thrust to the popularity of antiseptic products.
March 17, 2020
·
4 min read
Biotech Bay
Pharmaceutical Filtration Market – Current Industry Scenario with Forecast by 2025
The global pharmaceutical filtration market is surging significantly due to the increase in manufacture of biologics and large molecules, advancements in nanofibers, increase production of generics market, and government rules for cleanrooms in pharmaceutical production.
March 17, 2020
·
4 min read
Pharm Country
Global Nuclear Medicine Market Benefits from Use of Radioactive Materials for Disease Detection
Transparency Market Research presents a new market study on the global nuclear medicine market for the forecast period between 2016 and 2024.
March 17, 2020
·
4 min read
Biotech Bay
Biobanks Market: Increased Research on Genomics to Drive Demand
Intense competition and continuous upsurge in the business demands are mandating the market players to come up with new deliverables that are innovative and services at competitive rates, notes TMR Research in its newest report.
March 17, 2020
·
3 min read
Pharm Country
Big Data and AI Promise Huge Potential for IoT Medical Devices Market
Recently, UK Biobank opened its mass repository of medical data to researchers.
March 17, 2020
·
4 min read
Drug Development
Novo Nordisk Pauses Three Clinical Trials Because of Non-Fatal Thrombotic Events
No more patients will be enrolled in the trials and current treatment “will cease” while they determine the risks and plans for the trials.
March 17, 2020
·
3 min read
·
Mark Terry
Drug Development
AstraZeneca’s Checkpoint Inhibitor Imfinzi Helps Overall Survival in Lung Cancer
“We are pleased to see the sustained and meaningful survival benefit of Imfinzi for patients with small cell lung cancer after more than two years median follow up,” said Jose Baselga, Astra Zeneca’s executive vice president, Oncology R&D.
March 17, 2020
·
2 min read
·
Mark Terry
Business
COVID-19’s Impact on Life Sciences Researchers
Work in the age of COVID-19 is in flux. Restrictions change daily, and life sciences researchers are finding their work lives considerably different than they were a few short weeks ago.
March 17, 2020
·
4 min read
·
Gail Dutton
Previous
2 of 22
Next